JAZZ - Jazz Pharmaceuticals EPS misses by $0.38 misses on revenue May, 05 2020 04:15 PM Jazz Pharmaceuticals plc Jazz Pharmaceuticals (NASDAQ:JAZZ): Q1 Non-GAAP EPS of $0.45 misses by $0.38; GAAP EPS of -$2.82 misses by $1.72.Revenue of $534.73M (+5.2% Y/Y) misses by $9.82M.Press ReleaseMore news on: Jazz Pharmaceuticals plc, Earnings news and commentary, Healthcare stocks news,